Core Viewpoint - The company announces a cash dividend distribution of 0.32 CNY per share for the fiscal year 2024, approved at the shareholders' meeting on June 20, 2025 [2][4]. Distribution Plan - The total number of shares for the dividend distribution is based on the company's total share capital of 1,632,225,965 shares, resulting in a total cash dividend payout of 522,312,308.80 CNY [4]. - The distribution is applicable to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the dividend record date [3]. Implementation Method - Cash dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation Limited, with shareholders who have designated trading able to receive their dividends on the payment date [5]. - Certain shareholders, including specific trust and investment companies, will receive their dividends directly from the company [6]. Taxation Details - For individual shareholders holding shares for over one year, the cash dividend is exempt from personal income tax, while those holding for less than one month will have their dividends fully taxed [7]. - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied, resulting in a net cash dividend of 0.288 CNY per share [8]. - Hong Kong investors will also receive a net cash dividend of 0.288 CNY per share after a 10% withholding tax [8]. - Other institutional investors will not have taxes withheld by the company, and the gross cash dividend is 0.32 CNY per share [9].
人福医药集团股份公司2024年年度权益分派实施公告